Indonesia seeks to launch home-grown Covid-19 vaccine in third quarter


A healthcare worker inoculates a woman with a dose of the Pfizer vaccine against the Covid-19 during a mass vaccination at a shopping mall in Jakarta. Indonesia has aimed to develop and manufacture its own vaccines domestically since the start of the pandemic. - Reuters

JAKARTA, Feb 20 (Jakarta Post/ANN): Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Indonesia , Covid-19 , Home Grown , Vaccine , Third Quarter , 2022

Next In Aseanplus News

Vietnam, Brazil step up cooperation in digital transformation
US climber’s body recovered from Broad Peak avalanche
Too many aspirants leave Sudurpaschim chief minister struggling to fill cabinet
Prabowo’s data claims during State of Nation address draw public scrutiny
Anwar writes to Prabowo over Felda investment issue in Indonesia
National Museum’s royal seal keycaps sell out within an hour
Russia fires missiles near Northern Territories off Hokkaido during military drill
India orders removal of Google Firebase accounts after spotting scam pattern
Marcos urges Filipinos: Draw courage, conviction from Ninoy Aquino’s legacy
Inspector among 10 GOF members held in Penang e-waste factory extortion probe

Others Also Read